NEW JERSEY - MULTISTATE PHARMACY JURISPRUDENCE
EXAMINATION (MPJE) QUESTIONS AND CORRECT ANSWERS
(VERIFIED ANSWERS) PLUS RATIONALES 2026 / Q&A INSTANT
DOWNLOAD PDF
99 Questions with Answers and Detailed Rationales
100 PERCENT GUARANTEED PASS
INSTANT DOWNLOAD ANSWERS INCLUDED
IMPORTANCE OF THIS DOCUMENT
This comprehensive examination preparation guide has been meticulously developed to help you succeed in the
NEW JERSEY - MULTISTATE PHARMACY JURISPRUDENCE EXAMINATION (MPJE) QUESTIONS AND
CORRECT ANSWERS (VERIFIED ANSWERS) PLUS RATIONALES 2026 / Q&A INSTANT DOWNLOAD PDF. It
contains 99 carefully selected questions that reflect the most current exam content and testing strategies. Each
question is accompanied by a correct answer and a detailed rationale that explains the underlying
pathophysiology, pharmacology, or clinical reasoning.
Self-Assessment – Test your knowledge and Exam Preparation – Familiarize yourself with the
identify areas requiring further question format and content
study areas
Concept Reinforcement – Deepen your Confidence Building – Develop test-taking
understanding through strategies and reduce
evidence-based exam anxiety
rationales
Time Management – Practice answering
questions under simulated
exam conditions
Review Summary 99 Questions
Foundations - Application - NEW Jersey Multistate Pharmacy Jurisprudence Examination MPJE AND
Correct PLUS Rationales 2026 / Q&a Instant Download PDF NEW Jersey Pharmacy LAW AND Multistate
Pharmacy Jurisprudence MPJE Professional Doctor OF Pharmacy Pharmd / Graduate-level Jurisprudence
All answers with rationales
,Table of Contents
Content Area Questions Key Topics
NEW Jersey Multistate 1-17 NEW Jersey, Pharmacist, Pharmacy, Prescription, Controlled
Pharmacy Jurisprudence
Examination MPJE AND
Correct PLUS Rationales
2026 / Q&a Instant Download
PDF NEW Jersey Pharmacy
LAW AND Multistate
Pharmacy Jurisprudence
MPJE Professional Doctor
OF Pharmacy Pharmd /
Graduate-level Jurisprudence
Pharmacy 18-34 NEW Jersey, Jersey Pharmacy, Prescription, Pharmacist S,
Pharmacy Technician
Pharmacist 35-51 NEW Jersey, Prescription, Pharmacy, Jersey Pharmacist,
Controlled Substance
Prescription 52-68 NEW Jersey, Pharmacy, Controlled, Pharmacist, Substance
Controlled 69-85 NEW Jersey, Pharmacy, Pharmacist, Prescription, Jersey LAW
Substance 86-99 NEW Jersey, Pharmacy, Pharmacist, Describes, Prescription
TOTAL 99 All questions include answers and detailed rationales
,Section A - NEW Jersey Multistate Pharmacy
Jurisprudence Examination MPJE AND Correct PLUS
Rationales 2026 / Q&a Instant Download PDF NEW Jersey
Pharmacy LAW AND Multistate Pharmacy Jurisprudence
MPJE Professional Doctor OF Pharmacy Pharmd /
Graduate-level Jurisprudence
Q1.
A New Jersey pharmacy receives an electronic prescription for a Schedule II controlled
substance that lacks the prescriber's DEA number but includes an electronic signature.
Under New Jersey law and DEA regulations, which action is legally required?
A. Dispense the prescription as written B. Contact the prescriber to obtain the DEA
because the electronic signature substitutes number and document the clarification
for the DEA number. before dispensing.
C. Refuse to dispense and report the D. Dispense only if the patient presents a
prescriber to the DEA for an invalid paper copy with the DEA number within 72
prescription. hours.
Correct: B - Contact the prescriber to obtain the DEA number and document the
clarification before dispensing.
Rationale:Federal DEA regulations require a valid DEA number on all controlled substance
prescriptions, including electronic ones. New Jersey law adopts this requirement; the
pharmacist must verify and document the DEA number before dispensing. Options A, C, and
D misstate the legal obligation or introduce unauthorized conditions.
Q2.
Which of the following best describes the legal status of a collaborative practice
agreement (CPA) between a New Jersey pharmacist and a physician for managing warfarin
therapy?
A. The CPA must be approved by the New B. The CPA allows the pharmacist to
Jersey Board of Medical Examiners and the independently adjust warfarin doses without
Board of Pharmacy before implementation. physician notification.
C. The CPA is valid only if the physician D. The CPA must be in writing, include
reviews each patient's INR weekly. specific protocols, and be maintained at the
practice site for inspection.
Correct: D - The CPA must be in writing, include specific protocols, and be maintained at
the practice site for inspection.
Page 3
, Section A - NEW Jersey Multistate Pharmacy Jurisprudence Examination MPJE AND Correct PLUS Rationales 2026 / Q&a Instant Download
PDF NEW Jersey Pharmacy LAW AND Multistate Pharmacy Jurisprudence MPJE Professional Doctor OF Pharmacy Pharmd / Graduate-level
Rationale: New Jersey regulations require CPAs to be written, include defined protocols, and
be readily available for inspection. They do not require dual board pre-approval, do not permit
independent practice without oversight, and do not mandate weekly INR review by the
physician. Option D accurately reflects the regulatory requirement.
Q3.
A New Jersey pharmacy compounds a sterile preparation that is assigned a beyond-use
date (BUD) of 14 days at room temperature. Which standard must be followed to justify
this BUD?
A. USP Chapter <795> for nonsterile B. USP Chapter <797> for sterile
compounding compounding
C. USP Chapter <800> for hazardous drugs D. New Jersey Board of Pharmacy sterile
compounding guidelines only
Correct: B - USP Chapter <797> for sterile compounding
Rationale:USP <797> sets standards for sterile compounding, including BUD assignment
based on risk levels. USP <795> applies to nonsterile compounding, and <800> addresses
hazardous drug handling. New Jersey adopts USP standards, but <797> is the specific
chapter for sterile BUDs.
Q4.
Under New Jersey's Prescription Monitoring Program (NJPMP), a pharmacist must report
dispensed controlled substances to the database within what timeframe?
A. 24 hours of dispensing B. 72 hours of dispensing
C. 7 days of dispensing D. By the end of the next business day
Correct: A - 24 hours of dispensing
Rationale:New Jersey requires dispensing reports to the NJPMP within 24 hours. This is
stricter than many states. Options B, C, and D are incorrect timeframes and would result in
noncompliance.
Q5.
A New Jersey pharmacist is asked to dispense a 90-day supply of a Schedule II controlled
substance. Which statement is correct?
A. Federal law permits up to a 90-day B. New Jersey law prohibits dispensing
supply for Schedule II if the prescriber more than a 30-day supply of any Schedule
indicates it is for chronic pain. II controlled substance.
Page 4
EXAMINATION (MPJE) QUESTIONS AND CORRECT ANSWERS
(VERIFIED ANSWERS) PLUS RATIONALES 2026 / Q&A INSTANT
DOWNLOAD PDF
99 Questions with Answers and Detailed Rationales
100 PERCENT GUARANTEED PASS
INSTANT DOWNLOAD ANSWERS INCLUDED
IMPORTANCE OF THIS DOCUMENT
This comprehensive examination preparation guide has been meticulously developed to help you succeed in the
NEW JERSEY - MULTISTATE PHARMACY JURISPRUDENCE EXAMINATION (MPJE) QUESTIONS AND
CORRECT ANSWERS (VERIFIED ANSWERS) PLUS RATIONALES 2026 / Q&A INSTANT DOWNLOAD PDF. It
contains 99 carefully selected questions that reflect the most current exam content and testing strategies. Each
question is accompanied by a correct answer and a detailed rationale that explains the underlying
pathophysiology, pharmacology, or clinical reasoning.
Self-Assessment – Test your knowledge and Exam Preparation – Familiarize yourself with the
identify areas requiring further question format and content
study areas
Concept Reinforcement – Deepen your Confidence Building – Develop test-taking
understanding through strategies and reduce
evidence-based exam anxiety
rationales
Time Management – Practice answering
questions under simulated
exam conditions
Review Summary 99 Questions
Foundations - Application - NEW Jersey Multistate Pharmacy Jurisprudence Examination MPJE AND
Correct PLUS Rationales 2026 / Q&a Instant Download PDF NEW Jersey Pharmacy LAW AND Multistate
Pharmacy Jurisprudence MPJE Professional Doctor OF Pharmacy Pharmd / Graduate-level Jurisprudence
All answers with rationales
,Table of Contents
Content Area Questions Key Topics
NEW Jersey Multistate 1-17 NEW Jersey, Pharmacist, Pharmacy, Prescription, Controlled
Pharmacy Jurisprudence
Examination MPJE AND
Correct PLUS Rationales
2026 / Q&a Instant Download
PDF NEW Jersey Pharmacy
LAW AND Multistate
Pharmacy Jurisprudence
MPJE Professional Doctor
OF Pharmacy Pharmd /
Graduate-level Jurisprudence
Pharmacy 18-34 NEW Jersey, Jersey Pharmacy, Prescription, Pharmacist S,
Pharmacy Technician
Pharmacist 35-51 NEW Jersey, Prescription, Pharmacy, Jersey Pharmacist,
Controlled Substance
Prescription 52-68 NEW Jersey, Pharmacy, Controlled, Pharmacist, Substance
Controlled 69-85 NEW Jersey, Pharmacy, Pharmacist, Prescription, Jersey LAW
Substance 86-99 NEW Jersey, Pharmacy, Pharmacist, Describes, Prescription
TOTAL 99 All questions include answers and detailed rationales
,Section A - NEW Jersey Multistate Pharmacy
Jurisprudence Examination MPJE AND Correct PLUS
Rationales 2026 / Q&a Instant Download PDF NEW Jersey
Pharmacy LAW AND Multistate Pharmacy Jurisprudence
MPJE Professional Doctor OF Pharmacy Pharmd /
Graduate-level Jurisprudence
Q1.
A New Jersey pharmacy receives an electronic prescription for a Schedule II controlled
substance that lacks the prescriber's DEA number but includes an electronic signature.
Under New Jersey law and DEA regulations, which action is legally required?
A. Dispense the prescription as written B. Contact the prescriber to obtain the DEA
because the electronic signature substitutes number and document the clarification
for the DEA number. before dispensing.
C. Refuse to dispense and report the D. Dispense only if the patient presents a
prescriber to the DEA for an invalid paper copy with the DEA number within 72
prescription. hours.
Correct: B - Contact the prescriber to obtain the DEA number and document the
clarification before dispensing.
Rationale:Federal DEA regulations require a valid DEA number on all controlled substance
prescriptions, including electronic ones. New Jersey law adopts this requirement; the
pharmacist must verify and document the DEA number before dispensing. Options A, C, and
D misstate the legal obligation or introduce unauthorized conditions.
Q2.
Which of the following best describes the legal status of a collaborative practice
agreement (CPA) between a New Jersey pharmacist and a physician for managing warfarin
therapy?
A. The CPA must be approved by the New B. The CPA allows the pharmacist to
Jersey Board of Medical Examiners and the independently adjust warfarin doses without
Board of Pharmacy before implementation. physician notification.
C. The CPA is valid only if the physician D. The CPA must be in writing, include
reviews each patient's INR weekly. specific protocols, and be maintained at the
practice site for inspection.
Correct: D - The CPA must be in writing, include specific protocols, and be maintained at
the practice site for inspection.
Page 3
, Section A - NEW Jersey Multistate Pharmacy Jurisprudence Examination MPJE AND Correct PLUS Rationales 2026 / Q&a Instant Download
PDF NEW Jersey Pharmacy LAW AND Multistate Pharmacy Jurisprudence MPJE Professional Doctor OF Pharmacy Pharmd / Graduate-level
Rationale: New Jersey regulations require CPAs to be written, include defined protocols, and
be readily available for inspection. They do not require dual board pre-approval, do not permit
independent practice without oversight, and do not mandate weekly INR review by the
physician. Option D accurately reflects the regulatory requirement.
Q3.
A New Jersey pharmacy compounds a sterile preparation that is assigned a beyond-use
date (BUD) of 14 days at room temperature. Which standard must be followed to justify
this BUD?
A. USP Chapter <795> for nonsterile B. USP Chapter <797> for sterile
compounding compounding
C. USP Chapter <800> for hazardous drugs D. New Jersey Board of Pharmacy sterile
compounding guidelines only
Correct: B - USP Chapter <797> for sterile compounding
Rationale:USP <797> sets standards for sterile compounding, including BUD assignment
based on risk levels. USP <795> applies to nonsterile compounding, and <800> addresses
hazardous drug handling. New Jersey adopts USP standards, but <797> is the specific
chapter for sterile BUDs.
Q4.
Under New Jersey's Prescription Monitoring Program (NJPMP), a pharmacist must report
dispensed controlled substances to the database within what timeframe?
A. 24 hours of dispensing B. 72 hours of dispensing
C. 7 days of dispensing D. By the end of the next business day
Correct: A - 24 hours of dispensing
Rationale:New Jersey requires dispensing reports to the NJPMP within 24 hours. This is
stricter than many states. Options B, C, and D are incorrect timeframes and would result in
noncompliance.
Q5.
A New Jersey pharmacist is asked to dispense a 90-day supply of a Schedule II controlled
substance. Which statement is correct?
A. Federal law permits up to a 90-day B. New Jersey law prohibits dispensing
supply for Schedule II if the prescriber more than a 30-day supply of any Schedule
indicates it is for chronic pain. II controlled substance.
Page 4
